A Pilot Study- The Impact of Health Education on Knowledge of Blood Pressure ControlIschaemic Heart Disease Patients

Abstract

Increased Blood Pressure is one of the main causes for ischemic heart disease, and effective management of Hypertension as a key to preventing both primary and secondary Ischemic heart disease. In primary prevention, keeping blood pressure at or below 140/90 mmHg is advised; in secondary prevention, levels of 130/85 mmHg were previously advised. In addition to acting alone to increase Ischemic heart disease (IHD) risk, hypertension also multiplies the likelihood of negative outcomes when it coexists with the other major IHD risk factors mentioned above. Numerous research and guideline recommendations had published over the past 20 years with the goals of explaining the pathophysiology of IHD, identifying an ideal blood pressure (BP) threshold at which to start pharmacotherapy, and defining the ideal pharmacologic components of a treatment plan. The goal blood pressure for IHD patients is generally agreed to be less than 140/90 mmHg. The prescribed pharmaceutical class (or classes) will vary depending on the coexisting conditions that each patient has. It is expected that 1.56 billion adults would have hypertension in 2025. In the South-East Asia region, hypertension claims the lives of up to 1500000 people per year; consequently, it is the world’s biggest cause of death (WHO). The study’s objective is to assess people who have ischemic heart disease (IHD awareness of blood pressure control). The pre-experimental research design for the project was authorized. Patients with ischemic heart disease (IHD) and stage I hypertension made up the study’s sample population. This pilot study’s findings demonstrate the effectiveness of lifestyle modification education on blood pressure control among patients with ischemic heart disease (IHD) who have primary hypertension in particular hospitals.